Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Economic Evaluation in Clinical Trials, 2nd Edition

Economic Evaluation in Clinical Trials, 2nd Edition Book Reviews methodological issues for cost analysis in the the book focuses on economic evaluation in clinical trial setting with relevant examples. clinical trials and the specific techniques of However, there are sections that could be cost analysis in the trial context and, from an improved to make it a more comprehensive economist viewpoint; it is a great resource and and accessible handbook to readers. For an extremely practical guide. example, the perspective of the economic References evaluation is not mentioned when discussing 1. Drummond MF, Sculpher MJ, Torrance GW, O’Brien the method, ‘gold standard’ or issues of BJ, Stoddart GL. Methods for the Economic Evaluation study design. Economic evaluation plays of Health Care Programs. 3rd ed. Oxford (UK): Oxford an important role in defining boundaries University Press; 2005. 2. Richardson J, Khan MA, Lezzi A, Maxwell A. Cross- for collecting the resource uses in trials national Comparison of Twelve Quality of Life doi: 10.1111/1753-6405.12438 (What are relevant costs and benefits in the Instruments: MIC Paper 7 Germany. AQoL Research Paper 85. Melbourne (AUST): Monash University Centre economic evaluation of the trial?); and the Economic Evaluation in for Health Economics; 2013. assessment of trial costs and benefits. Ideally, the perspective of the economic evaluation Clinical Trials, 2nd Edition should be mentioned at the beginning of Edited by Henry A. Glick, Jalpa A. Doshi, the chapter where the ‘gold standard’ is Seema S. Sonnad and Daniel Polsky. Oxford discussed, in the preplanning in preparation University Press, 2015. ISBN 978-0-199685- for the trial section, or at least briefly 028; 272 pages; RRP £34.99 discussed with reference to other sources for further reading (e.g. Drummond et al.’s Reviewed by Mrs Ha D.N. Le Methods for the economic evaluation of health Deakin Health Economics, Population Health SRC, Deakin University, Victoria care programmes ). In addition, the section on instruments for Among the many handbooks on health assessing QALYs in trials does not include economic evaluation available, Economic any discussion of the sensitivity to the Evaluation in Clinical Trials, now in its second dimensions of these instruments, which is edition, will be of interest to researchers who quite important in the choice of instruments. work in health economic fields worldwide. It would add further insights to readers if This well-structured and updated book a more comprehensive comparison of the provides information on the methods for instruments is added (e.g. Richardson et conducting economic evaluations alongside al. 2013 ).The Assessment Quality of Life clinical trials; in particular, designing measure (AQoL) could have been mentioned economic evaluations in clinical trials, in this section, given the growing use of this preplanning in preparation for the trials, instrument in many clinical trials worldwide. and the transferability of the results from Finally, it would be helpful for readers if trials. It also provides helpful guidance on the authors had added a brief section on techniques for collecting cost data, analysing presenting the results or reporting the the data and interpreting the results, as well economic evaluation in trials, either after as the issues of using these techniques in the section on transferability of the results implementing the economic evaluation. The from the trials or following the discussion techniques presented and their issues and on relevance of trial-based economic potential approaches are illustrated through analyses. The inclusion of a reference to the practical case studies and examples, which Consolidated Health Economic Evaluation are carefully explained and discussed. Reporting Standards (CHEERS) checklist This new edition extends the strengths of the would also be helpful. first edition in a coherent and understandable Overall, this book is practical and useful. I way, with important information added or would recommend it for those working on clarified. Designing economic evaluations economic analyses alongside clinical trials. in clinical trials is updated with discussion The language used in the book is clear and of the instruments used for medical service assessable to audiences who are in the health data collection, for collecting work loss data economics field or for those with analytical and for protocol-induced cost. There is also and statistical skills. This book is aimed at an update of the comparison of different readers who study or work in the field of instruments used to calculate Quality economics, health economics or public health Adjusted Life Years (QALYs); in particular, – such as public health and health economic the inclusion of the SF-6D in comparison students, lecturers, researchers, health care to the HUI2, HUI3 or EQ-5D, including a policy makers and health service professionals. discussion of the minimum important Readers should not expect to find a step-by- differences of these instruments and the step guide of how to conduct an economic methods of administration. The book includes evaluation, what economic evaluation means important updates on techniques and or the types of economic evaluation. Rather, 594 Australian and New Zealand Journal of Public Health 2015 vol . 39 no . 6 © 2015 Public Health Association of Australia http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australian and New Zealand Journal of Public Health Wiley

Economic Evaluation in Clinical Trials, 2nd Edition

Australian and New Zealand Journal of Public Health , Volume 39 (6) – Dec 1, 2015
Download PDF
1 page

Loading next page...
 
/lp/wiley/economic-evaluation-in-clinical-trials-2nd-edition-21Aw5BWLz4

References (3)

Publisher
Wiley
Copyright
© 2015 Public Health Association of Australia
ISSN
1326-0200
eISSN
1753-6405
DOI
10.1111/1753-6405.12438
Publisher site
See Article on Publisher Site

Abstract

Book Reviews methodological issues for cost analysis in the the book focuses on economic evaluation in clinical trial setting with relevant examples. clinical trials and the specific techniques of However, there are sections that could be cost analysis in the trial context and, from an improved to make it a more comprehensive economist viewpoint; it is a great resource and and accessible handbook to readers. For an extremely practical guide. example, the perspective of the economic References evaluation is not mentioned when discussing 1. Drummond MF, Sculpher MJ, Torrance GW, O’Brien the method, ‘gold standard’ or issues of BJ, Stoddart GL. Methods for the Economic Evaluation study design. Economic evaluation plays of Health Care Programs. 3rd ed. Oxford (UK): Oxford an important role in defining boundaries University Press; 2005. 2. Richardson J, Khan MA, Lezzi A, Maxwell A. Cross- for collecting the resource uses in trials national Comparison of Twelve Quality of Life doi: 10.1111/1753-6405.12438 (What are relevant costs and benefits in the Instruments: MIC Paper 7 Germany. AQoL Research Paper 85. Melbourne (AUST): Monash University Centre economic evaluation of the trial?); and the Economic Evaluation in for Health Economics; 2013. assessment of trial costs and benefits. Ideally, the perspective of the economic evaluation Clinical Trials, 2nd Edition should be mentioned at the beginning of Edited by Henry A. Glick, Jalpa A. Doshi, the chapter where the ‘gold standard’ is Seema S. Sonnad and Daniel Polsky. Oxford discussed, in the preplanning in preparation University Press, 2015. ISBN 978-0-199685- for the trial section, or at least briefly 028; 272 pages; RRP £34.99 discussed with reference to other sources for further reading (e.g. Drummond et al.’s Reviewed by Mrs Ha D.N. Le Methods for the economic evaluation of health Deakin Health Economics, Population Health SRC, Deakin University, Victoria care programmes ). In addition, the section on instruments for Among the many handbooks on health assessing QALYs in trials does not include economic evaluation available, Economic any discussion of the sensitivity to the Evaluation in Clinical Trials, now in its second dimensions of these instruments, which is edition, will be of interest to researchers who quite important in the choice of instruments. work in health economic fields worldwide. It would add further insights to readers if This well-structured and updated book a more comprehensive comparison of the provides information on the methods for instruments is added (e.g. Richardson et conducting economic evaluations alongside al. 2013 ).The Assessment Quality of Life clinical trials; in particular, designing measure (AQoL) could have been mentioned economic evaluations in clinical trials, in this section, given the growing use of this preplanning in preparation for the trials, instrument in many clinical trials worldwide. and the transferability of the results from Finally, it would be helpful for readers if trials. It also provides helpful guidance on the authors had added a brief section on techniques for collecting cost data, analysing presenting the results or reporting the the data and interpreting the results, as well economic evaluation in trials, either after as the issues of using these techniques in the section on transferability of the results implementing the economic evaluation. The from the trials or following the discussion techniques presented and their issues and on relevance of trial-based economic potential approaches are illustrated through analyses. The inclusion of a reference to the practical case studies and examples, which Consolidated Health Economic Evaluation are carefully explained and discussed. Reporting Standards (CHEERS) checklist This new edition extends the strengths of the would also be helpful. first edition in a coherent and understandable Overall, this book is practical and useful. I way, with important information added or would recommend it for those working on clarified. Designing economic evaluations economic analyses alongside clinical trials. in clinical trials is updated with discussion The language used in the book is clear and of the instruments used for medical service assessable to audiences who are in the health data collection, for collecting work loss data economics field or for those with analytical and for protocol-induced cost. There is also and statistical skills. This book is aimed at an update of the comparison of different readers who study or work in the field of instruments used to calculate Quality economics, health economics or public health Adjusted Life Years (QALYs); in particular, – such as public health and health economic the inclusion of the SF-6D in comparison students, lecturers, researchers, health care to the HUI2, HUI3 or EQ-5D, including a policy makers and health service professionals. discussion of the minimum important Readers should not expect to find a step-by- differences of these instruments and the step guide of how to conduct an economic methods of administration. The book includes evaluation, what economic evaluation means important updates on techniques and or the types of economic evaluation. Rather, 594 Australian and New Zealand Journal of Public Health 2015 vol . 39 no . 6 © 2015 Public Health Association of Australia

Journal

Australian and New Zealand Journal of Public Health – Wiley

Published: Dec 1, 2015

There are no references for this article.